Development and validation of laboratory procedures using next generation sequencing technologies to assess genes causing severe combined immune deficiency (SCID) in state newborn screening laboratories

This FOA is to develop, improve, and implement laboratory techniques to assess babies born with severe combined immune deficiency (SCID) and other primary immunodeficiencies using next generation sequencing technologies as a second tier test in state newborn screening aboratories. CDC seeks to evaluate the potential of using next generation sequencing technologies in the state newborn screening laboratory setting. Results of this activity will be used to inform other state newborn screening laboratories about the feasibility of using next generation sequencing technologies in the state newborn screening...

State governments,County governments,City or township governments,Special district governmentsIndependent school districts,Public and State controlled institutions of higher education,Native American tribal governments (Federally recognized),Public housing authorities/Indian housing authorities,Native American tribal organizations (other than Federally recognized tribal governments),Nonprofits having a 501(c)(3) status with the IRS, other than institutions ofhigher education,Nonprofits without 501(c)(3) status with the IRS, other than institutions ofhigher education,Private institutions of higher education,For profit organizations other than small businesses,Small businesses,Others (see text field entitled "Additional Information on Eligibility" for clarification),Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

CDC Technical Information Management Section (TIMS) Procurement and Grants Office Telephone 770-488-2700 Email: PGOTIM@cdc.gov Hours: Monday - Friday, 7am – 4:30pm U.S. Eastern Standard Time